Company Monitoring Page for Purdue-Pharma

latest headlines for company on cafepharma

Embattled Purdue Pharma asks judge to authorize $34M in employee bonuses
The Hill
Fri, 09/20/19 - 09:40 am
Tags:
Purdue Pharma, bankruptcy, bonuses
Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy
Stat
Mon, 09/16/19 - 09:30 am
Tags:
Purdue Pharma, oxycontin, bankruptcy, opioids, opioid crisis
NY AG uncovers $1 billion in Sackler family wire transfers amid opioid probe: report
NY Times, NY
Fri, 09/13/19 - 07:04 pm
Tags:
New York, Sackler family, Purdue Pharma, opioids, opioid crisis
At least 20 states and D.C. reject settlement with OxyContin maker Purdue Pharma
NBC News
Thu, 09/12/19 - 10:49 pm
Tags:
Purdue Pharma, legal, opioids, opioid crisis
Who joins Purdue on pharma's top settlements list? Merck, GSK and Pfizer, for starters
Fierce Pharma
Thu, 09/12/19 - 12:01 pm
Tags:
Purdue Pharma, legal, Merck, GSK, Pfizer
Purdue inks multibillion-dollar opioid deal with thousands of local governments, 23 states: reports
Fierce Pharma
Wed, 09/11/19 - 11:51 pm
Tags:
Purdue Pharma, opioids, opioid crisis
Purdue talks may have stalled with state AGs, but cities and counties are still at it: AP
Fierce Pharma
Mon, 09/9/19 - 08:13 pm
Tags:
Purdue Pharma, opioids, opioid crisis, bankruptcy
Purdue Pharma touts data to fight lawsuits that downplay its role in the opioid epidemic
Stat
Mon, 09/9/19 - 10:31 am
Tags:
Purdue Pharma, opioids, opioid crisis
How Will Johnson & Johnson's Opioid Case Ruling Impact Big Pharma Stocks?
Motley Fool
Thu, 09/5/19 - 08:17 pm
Tags:
opioids, opioid crisis, JNJ, McKesson, Mallinckrodt, Teva Pharmaceutical, Purdue Pharma, Par Pharma, Actavis
Purdue preps bankruptcy as opioid settlement bid stumbles; report
Pharmaforum
Thu, 09/5/19 - 10:06 am
Tags:
Purdue Pharma, opioids, opioid crisis, bankruptcy
State attorneys general dubious about Purdue's reported $12B opioid settlement offer: WSJ
Fierce Pharma
Fri, 08/30/19 - 10:51 am
Tags:
Purdue Pharma, Sackler family, opioids, opioid crisis, New York, Connecticut, Massachusetts
Report: Purdue Pharma Offered $10-12 Billion To Settle Thousands Of Opioid Lawsuits
Forbes
Tue, 08/27/19 - 11:09 pm
Tags:
Purdue Pharma, opioids, opioid crisis
[video]Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing
Stat
Tue, 08/27/19 - 09:44 am
Tags:
Sackler family, Dr. Richard Sackler, Purdue Pharma, oxycontin, opioids, Kentucky, opioid crisis
Purdue Pharma seeks to minimize its role in opioid crisis as it urges dismissal of Massachusetts suit
Stat
Sat, 08/3/19 - 12:04 am
Tags:
Purdue Pharma, Massachusetts, opioids, opioid crisis
The Sacklers strip-mined Purdue to avoid billions in settlements: Arizona AG
Fierce Pharma
Fri, 08/2/19 - 11:08 am
Tags:
Purdue Pharma, Arizona, opioids, opioid crisis, Supreme Court, Sackler family
McKinsey under fire for consulting on opioid sales
Beckers Hospital Review
Mon, 07/29/19 - 11:20 pm
Tags:
McKinsey, JNJ, Purdue Pharma, opioids, opioid crisis
Opioid and price fixing legal liabilities mount for generic companies
Biopharma Dive
Mon, 07/22/19 - 08:08 pm
Tags:
generics, opioids, price fixing, Purdue Pharma, Mylan, Endo, Amneal, Teva Pharmaceutical
3 drugmakers dominated opioid supplies as 76B pills flooded the U.S.: report
Fierce Pharma
Wed, 07/17/19 - 10:50 pm
Tags:
opioids, opioid crisis, McKesson, Walgreens, Cardinal Health, AmerisourceBergen, CVS Health, Mallinckrodt, Teva Pharmaceutical, Endo, Purdue Pharma
After Oklahoma payout, Purdue faces 5 new state lawsuits over OxyContin
Fierce Pharma
Fri, 05/17/19 - 01:01 pm
Tags:
Purdue Pharma, oxycontin, opioids, Oklahoma
Eisai buys Purdue stake in insomnia drug as PDUFA date nears
Fierce Biotech
Wed, 05/1/19 - 10:46 am
Tags:
Eisai, Purdue Pharma, insomnia, lemborexant, FDA

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.